Medlab Clinical LTD sell "MultiBiotic™"

MultiBiotic is an evidence-based, multi-species probiotic designed to target end-organ function and support gastrointestinal health. It is ARTG-listed and available in pharmacies and to healthcare providers in Australia, New Zealand, Singapore, and Hong Kong, and is currently in Phase 1 clinical trials for chemotherapy-induced mucositis and neutropenia (ANZCTR: ACTRN12618000927224), an exploratory pilot study assessing the safety and tolerability of the multi-species probiotic formulation in chemotherapy-induced intestinal mucositis/diarrhea. Related publications include work by Thomsen, Clarke, and Vitetta (2018) on adjuvant probiotics attenuating intestinal inflammatory responses from cancer treatment, and further research by Palacios, Vitetta, Coulson, Madigan, Lam, Manuel, Briskey, and colleagues.